demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
ivermectin Bukhari Ahmed Kirti Chachar Babalola Chaccour RIVET-COV ... Abd-Elsalam Krolewiecki I-TECH ... Shahbaznejad Mayer
ivermectin plus doxycycline NCT04523831 ...

7 studies excluded by filtering options 1

6064 Glorial F, 2020 1100not a RCTrisk of bias not avaialble
6381 Espitia-Hernandez, 2020 1310not a RCTrisk of bias not avaialble
6382 Khan, 2020 0130selection pending
6383 Soto-Becerra, 2020 0122selection pending
6384 Spoorthi, 2020 1310not a RCTrisk of bias not avaialble
6625 Nasir, 2020 2310excludednot a RCTrisk of bias not avaialble
7995 Hazan, 2021 2320excludednot a RCTrisk of bias not avaialble